In the United States, the list price of a 4-week supply of semaglutide or tirzepatide ranges from USD 900 to 1,350 [120,121], rendering them inaccessible for uninsured or underinsured patients
For antacids specifically, there is no evidence suggesting that Wegovy alters their effectiveness or safety profile
In a clinical trial, retatrutide showed major improvements in managing blood sugar levels
Later, when I returned to the site, all GLP-1 options had been removed without notice
Certain weight loss agents contain stimulants such as caffeine, synephrine, or compounds structurally similar to amphetamines
meeting these thresholds may unlock coverage